Ian F Tannock

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Drug Administration

Radical Prostatectomy

Prostate Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher M Booth, Elizabeth A Eisenhauer, Bishal Gyawali, Ian F Tannock
Reply to D.J. Stewart et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Christopher M Booth, Elizabeth A Eisenhauer, Bishal Gyawali, Ian F Tannock
Reply to D.J. Stewart et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (8) (2024)
Christopher M Booth, Elizabeth A Eisenhauer, Bishal Gyawali, Ian F Tannock
Reply to D.J. Stewart et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (8) (2024)
Christopher M Booth, Elizabeth A Eisenhauer, Bishal Gyawali, Ian F Tannock
Progression-Free Survival Should Not Be Used as a Primary End Point for Registration of Anticancer Drugs. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ian F Tannock, Daniel A Goldstein, Jonathan Ofer, Bishal Gyawali, Tomer Meirson
Evaluating Trials of Adjuvant Therapy: Is There Benefit for People With Resected Renal Cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Adi Kartolo, Ian F Tannock, Francisco Emilio Vera-Badillo
Management of Metastatic Hormone-Sensitive Prostate Cancer: Is Docetaxel Needed? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (31) (2022)
Kelvin Kar-Wing Chan, Ian F Tannock
Should Basket Trials Be Pathways to Drug Registration for Biomarker-Defined Subgroups of Advanced Cancers? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (22) (2021)
Mark J Ratain, Ian F Tannock, Allen S Lichter
Dose Optimization of Sotorasib: Is the US Food and Drug Administration Sending a Message? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (31) (2021)
Ian F Tannock, Mark J Ratain, Daniel A Goldstein, Allen S Lichter, Gary L Rosner, Leonard B Saltz
Near-Equivalence: Generating Evidence to Support Alternative Cost-Effective Treatments. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (9) (2021)